Kazia Therapeutics Deal History & Licensing Activity
Kazia Therapeutics is a biotech headquartered in US. The company currently has 6 active clinical trials, primarily in Solid Tumors.
Deals (12mo)
1
Active Trials
6
Top Modality
N/A
Focus Area
Solid Tumors
Kazia Therapeutics Pipeline Focus
Therapeutic areas and modalities where Kazia Therapeutics is most active based on deal history and clinical trial data.
Therapeutic Areas
Kazia Therapeutics Clinical Pipeline
Kazia Therapeutics has 6 active clinical trials across 2 development phases.
3
Phase 1
3
Phase 2
See How Your Asset Matches Kazia Therapeutics's Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Solid Tumors assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
About Kazia Therapeutics Licensing & Deal Activity
Kazia Therapeutics is a biotech company based in US that has been actively engaged in licensing transactions across the biopharma landscape.
Key therapeutic areas of focus for Kazia Therapeutics include Solid Tumors (2 deals and trials), CNS Disorders (1 deal and trial), and Hematological Malignancies (1 deal and trial).
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Kazia Therapeutics and 850+ other biopharma companies. Use our Solidus to benchmark your asset against Kazia Therapeutics's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.